drugset / Trial / NCT02475161
A Study to Investigate the Effect of Increased Gastric pH on the Oral Bioavailability of the Orexin-2 Receptor Antagonist JNJ-42847922 in Healthy Participants
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the effects of daily administration of rabeprazole on the single-dose pharmacokinetics of JNJ-42847922 in healthy participants.
Timeline
- Start
- 2015-06
- Primary completion
- 2015-07
- Completion
- 2015-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rabeprazole | Small molecule | 20 mg | Oral |
| Subject | Seltorexant | Small molecule | 20 mg | Oral |
Indications
No indication recorded.